4.6 Article

Myc-ARF (alternate reading frame) interaction inhibits the functions of Myc

Journal

JOURNAL OF BIOLOGICAL CHEMISTRY
Volume 279, Issue 35, Pages 36698-36707

Publisher

AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
DOI: 10.1074/jbc.M312305200

Keywords

-

Funding

  1. NCI NIH HHS [CA 100035, CA 55079, CA 88863] Funding Source: Medline
  2. NIGMS NIH HHS [GM 54709] Funding Source: Medline

Ask authors/readers for more resources

The tumor suppressor protein ARF (alternate reading frame) inhibits MDM2 to stabilize and activate the functions of p53. Here we provide evidence for an additional activity of ARF that attenuates cell cycle progression independently of p53 activation. We show that ARF interacts with c-Myc independently of MDM2 or p53. Consequently, ARF relocalizes c-Myc from the nucleoplasm to the nucleolus. Binding and relocalization by ARF correlate with an inhibition of the c-Myc-activated transcription in both p53-positive and -negative cells. Using inducible cell lines, we show that the wild type ARF, but not a mutant, inhibits expression of the c-Myc-induced genes before inhibiting S phase. Moreover, ARF inhibits Myc-induced progression into S phase in cells lacking p53 or expressing a defective p53, indicating that ARF inhibits the S phase stimulatory function of c-Myc independently of p53. Our results strongly suggest that c-Myc is a bona fide target of ARF and that ARF attenuates c-Myc independently of the ARF-p53 axis.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available